Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The primary objective of this study is to compare the urinary excretion of 14C-labeled risedronate and alendronate over 28 days.
Epistemonikos ID: cde0f3c68097a9f8012e691f0fa78d7699941a5a
First added on: May 04, 2024